EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma
2015 · Nature Communications · 136 citations
https://doi.org/10.1038/ncomms9494
W
Weijuan Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
226
Papers
4.9K
Citations
34
h-index
98
i10-index
Weijuan Zhang is an academic researcher from Beijing Institute of Fashion Technology. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Bladder and Urothelial Cancer Treatments & Renal cell carcinoma treatment. The author has an h-index of 34, co-authored 193 publications.
ORCID: 0000-0003-3494-3114Papers by this author
worksPrognostic Value of Diametrically Polarized Tumor-Associated Macrophages in Renal Cell Carcinoma
2014 · Annals of Surgical Oncology · 122 citations
https://doi.org/10.1245/s10434-014-3601-1
Decreased Expression of Hepatocyte Nuclear Factor 4α (Hnf4α)/MicroRNA-122 (miR-122) Axis in Hepatitis B Virus-associated Hepatocellular Carcinoma Enhances Potential Oncogenic GALNT10 Protein Activity
2014 · Journal of Biological Chemistry · 93 citations
https://doi.org/10.1074/jbc.m114.601203
DNA-dependent Activator of Interferon-regulatory Factors (DAI) Promotes Lupus Nephritis by Activating the Calcium Pathway
2013 · Journal of Biological Chemistry · 72 citations
https://doi.org/10.1074/jbc.m113.457218
High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma
2015 · Scientific Reports · 63 citations
https://doi.org/10.1038/srep16954
Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma
2019 · Cancer Immunology Immunotherapy · 44 citations
https://doi.org/10.1007/s00262-019-02314-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat